Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
出版商更正：HER2相关生物标志物可预测HER2表达转移性结直肠癌患者接受曲妥珠单抗德鲁替康治疗的临床结果：DESTINY-CRC01研究的生物标志物分析
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-56170-9
Siena, Salvatore; Raghav, Kanwal; Masuishi, Toshiki; Yamaguchi, Kensei; Nishina, Tomohiro; Elez, Elena; Rodriguez, Javier; Chau, Ian; Di Bartolomeo, Maria; Kawakami, Hisato; Suto, Fumitaka; Koga, Makito; Inaki, Koichiro; Kuwahara, Yusuke; Takehara, Issey; Barrios, Daniel; Kobayashi, Kojiro; Grothey, Axel; Yoshino, Takayuki
